USFDA Open Form 483 (Mar'16) for Goa unit: Management expects clarity from the US FDA over next few months. The Company has already given monthly update to the US drug regulator. LPC has already received Establishment Inspection Report (EIR) for first set of observations (against Form 483 issued in July 2015 to its Goa facility) and also tentative approval from the US FDA. Though the issues are not seemingly contentious enough which...